Copertina

A Flexible Seamless Phase 2/3 Design With Biomarker‐Driven Subgroup Enrichment and Sample Size Re‐Estimation

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Zizhong Tian, Liwen Wu, Rachael Liu, Jianchang Lin
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Pharmaceutical Statistics
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Sample Size Estimation Using a Partially Clustered Frailty Model for Biomarker‐Strategy Designs With Multiple Treatments
di: Derek Dinart, et al.
Pubblicazione: (2024)

An Adaptive Three‐Arm Comparative Clinical Endpoint Bioequivalence Study Design With Unblinded Sample Size Re‐Estimation and Optimized Allocation Ratio
di: David Hinds, et al.
Pubblicazione: (2024)

Bayesian Solutions for Assessing Differential Effects in Biomarker Positive and Negative Subgroups
di: Dan Jackson, et al.
Pubblicazione: (2024)

Sample Size Estimation for Correlated Count Data With Changes in Dispersion
di: Jintong Hou, et al.
Pubblicazione: (2025)

Correction to “Sample Size Estimation for Correlated Count Data With Changes in Dispersion”
Pubblicazione: (2025)

Drift Parameter Based Sample Size Determination in Multi‐Stage Bayesian Randomized Clinical Trials
di: Yueyang Han, et al.
Pubblicazione: (2025)

Bayesian Hierarchical Models for Subgroup Analysis
di: Yun Wang, et al.
Pubblicazione: (2024)

Subgroup Identification Based on Quantitative Objectives
di: Yan Sun, et al.
Pubblicazione: (2024)

Investigating Stability in Subgroup Identification for Stratified Medicine
di: G. M. Hair, et al.
Pubblicazione: (2024)

Predictive Biomarker Graphical Approach ( PRIME ) for Precision Medicine
di: Gina D’Angelo, et al.
Pubblicazione: (2026)

A Phase I Dose‐Finding Design Incorporating Intra‐Patient Dose Escalation
di: Beibei Guo, et al.
Pubblicazione: (2024)

Consistency Assessment and Regional Sample Size Calculation for MRCT Under Random Effects Model
di: Xinru Ren, et al.
Pubblicazione: (2026)

A Weighted Geometric Average Hazard Ratio Based Sample Size Formula for Non‐Proportional Hazards and Its Application to a Smoothed Piecewise Model in Cancer Immunotherapy Trial Design
di: Qingyang Zhang, et al.
Pubblicazione: (2025)

Bayesian Power‐Based Sample Size Determination for Single‐Arm Clinical Trials With Time‐to‐Event Endpoints
di: Go Horiguchi, et al.
Pubblicazione: (2026)

CUSUMIN Combination: A Cumulative Sum Interval Design for Phase I Cancer Drug‐Combination Trials
di: Tomoyoshi Hatayama, et al.
Pubblicazione: (2025)

A Bayesian Dynamic Model‐Based Adaptive Design for Oncology Dose Optimization in Phase I/II Clinical Trials
di: Yingjie Qiu, et al.
Pubblicazione: (2024)

Tutorial on Firth's Logistic Regression Models for Biomarkers in Preclinical Space
di: Gina D'Angelo, et al.
Pubblicazione: (2024)

PKBOIN‐12: A Bayesian Optimal Interval Phase I/II Design Incorporating Pharmacokinetics Outcomes to Find the Optimal Biological Dose
di: Hao Sun, et al.
Pubblicazione: (2024)

BOIN ‐ MEM : A Two‐Stage Design for Dose Optimization With Information Borrowing Across Dose Levels and Stages in Oncology Phase I/ II Trials
di: Ryo Kitabayashi, et al.
Pubblicazione: (2025)

An Association Test for Ordinal Outcomes in Clustered Data With Informative Cluster Size
di: Hasika K. Wickrama Senevirathne, et al.
Pubblicazione: (2026)

Great Wall: A Generalized Dose Optimization Design for Drug Combination Trials Maximizing Survival Benefit
di: Yan Han, et al.
Pubblicazione: (2025)

Sample size calculation for comparing two ROC curves
di: Sin‐Ho Jung
Pubblicazione: (2024)

New, Shorter Small‐Sample Intervals for Vaccine Efficacy
di: Mauro Gasparini, et al.
Pubblicazione: (2026)

Statistical Consideration for Event‐Free Survival With Cure Rate in Acute Myeloid Leukemia Studies
di: Yuichiro Kaneko, et al.
Pubblicazione: (2025)

Potency Assay Variability Estimation in Practice
di: Hang Li, et al.
Pubblicazione: (2024)

A Likelihood Perspective on Dose‐Finding Study Designs in Oncology
di: Zhiwei Zhang
Pubblicazione: (2024)

A Bayesian Hybrid Design With Borrowing From Historical Study
di: Zhaohua Lu, et al.
Pubblicazione: (2024)

Applying Bias Correction Methods to Build Hybrid Controls Using Real‐World Patients for a Phase IIb Randomized Controlled Trial of Baricitinib for Rheumatoid Arthritis
di: Heather J. Litman, et al.
Pubblicazione: (2025)

Optimal Cut‐Point Selection Methods Under Binary Classification When Subclasses Are Involved
di: Jia Wang, et al.
Pubblicazione: (2024)

Estimation of the odds ratio from multi‐stage randomized trials
di: Shiwei Cao, et al.
Pubblicazione: (2024)

Designing and Evaluating Bayesian Advanced Adaptive Randomised Clinical Trials: A Practical Guide
di: Anders Granholm, et al.
Pubblicazione: (2025)

Phase III Probability of Success When Early Development Is Based on a Putative Surrogate Endpoint: A Vaccine Efficacy Case Study
di: Andrea Callegaro, et al.
Pubblicazione: (2026)

Quality by Design for Preclinical In Vitro Assay Development
di: Jonathan Jones, et al.
Pubblicazione: (2024)

Adaptive Constrained Weighted Estimation for Incorporating Multiple External Information Sources
di: Keita Takahashi, et al.
Pubblicazione: (2025)

“Within‐Trial” Prognostic Score Adjustment Is Targeted Maximum Likelihood Estimation
di: Emilie Højbjerre‐Frandsen, et al.
Pubblicazione: (2026)

Variable Duration Trial as an Alternative Design for Continuous Endpoints
di: Jitendra Ganju, et al.
Pubblicazione: (2024)

A Model‐Based Trial Design With a Randomization Scheme Considering Pharmacokinetics Exposure for Dose Optimization in Oncology
di: Jun Zhang, et al.
Pubblicazione: (2024)

Methodological Approaches for the Estimation of Confidence Intervals on Partial Youden Index Under Verification Bias
di: Sihan Jia, et al.
Pubblicazione: (2026)

Finding the Optimal Number of Splits and Repetitions in Double Cross‐Fitting Targeted Maximum Likelihood Estimators
di: Mohammad Ehsanul Karim, et al.
Pubblicazione: (2025)

Estimation of Treatment Policy Estimands for Continuous Outcomes Using Off‐Treatment Sequential Multiple Imputation
di: Thomas Drury, et al.
Pubblicazione: (2024)